Motor Imagery and Functional Performance in Diplegic Cerebral Palsy
NCT ID: NCT07287215
Last Updated: 2025-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
99 participants
OBSERVATIONAL
2025-11-24
2026-02-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motor Imagery Ability Assessment
Laterality Task (Choice Task): Implicit Motor Imagery capacity will be measured through a laterality task, which involves deciding which side a limb belongs to. Right-left discrimination of the foot will be assessed using the "Recognize Foot" application developed by the Neuro Orthopaedic Institute
Mental Stopwatch Paradigm
A mental stopwatch will be used to assess explicit MI capacity. This paradigm compares the time between the actual movement duration and the duration of a similar imagined task.
Functional Mobility
Functional Mobility: Functional Mobility will be assessed using the Functional Mobility Scale (FMS) and the Timed Up and Go test.
Gait assessment:
Gait assessment: The Gillette FDA is a self- or observer-based assessment tool.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being between 5 and 18 years of age
* Being between levels I and III on the GMFCS
* Having the cognitive ability to follow the assessment instructions
* Informed consent form has been obtained from the child's family
* The child has agreed to participate voluntarily in the study
Exclusion Criteria
* Having additional diagnoses such as epilepsy or autism spectrum disorder
* Demonstrating cognitive or behavioral problems that prevent them from following instructions during the assessment
* Having informed consent from the child's family or the child
5 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inonu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dilan Demirtaş Karaoba
assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bingöl
Bingöl, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
dilan demirtas karaoba, asst. prof, asst. prof
Role: CONTACT
Phone: +905541127796
Email: [email protected]
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Büşra Candiri, asst. prof
Role: primary
Hasan BİNGÖL, asst. prof
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025/0725
Identifier Type: -
Identifier Source: org_study_id